Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study

医学 内科学 鼻咽癌 肿瘤科 危险系数 放化疗 诱导化疗 比例危险模型 单变量分析 多元分析 化疗 放射治疗 置信区间
作者
Xiaoli Mu,Hongyan Liu,Juan Wu,Shi Chen,Xingchen Peng,Jing Wang,Zhigong Wei,Ling He,Ji-Yan Liu,Zejun Lu,Yonglin Su
出处
期刊:Aging [Impact Journals, LLC]
卷期号:14 (16): 6727-6739
标识
DOI:10.18632/aging.204246
摘要

Background: Currently available evidence favors the combination of chemotherapy with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma (LANPC). However, the optimal timing for additional chemotherapy is unclear. This study was conducted to compare the efficacy and toxicity of induction chemotherapy plus concurrent chemoradiotherapy (IC+CCRT) versus concurrent chemoradiotherapy plus adjuvant chemotherapy (CCRT+AC). Methods: Two medical centers in China enrolled patients with LANPC (stage III-IVB) between January 2009 and May 2020. Through the use of propensity score matching (PSM), baseline characteristics were balanced. The primary endpoint was overall survival (OS), which was evaluated by the Kaplan-Meier method and log-rank test. Potential independent prognostic factors were identified using univariate and multivariate Cox proportional hazard analyses. Based on the chi-squared test, we compared the adverse events associated with treatment between the groups. Results: After the implementation of PSM, 159 patients treated with IC+CCRT and 72 patients treated with CCRT+AC were eventually enrolled in this study. There was no significant difference between patients treated with IC+CCRT and CCRT+AC in terms of 3-year OS (94.7% versus 90.9%, p=0.816), progression-free survival (PFS) (91.2% versus 83.1%, p=0.588), locoregional recurrence-free survival (LRFS) (92.5% versus 81.8%, p=0.478), or distant metastasis-free survival (DMFS) (93.4% versus 88.2%, p=0.783). There was no prognostic significance of the treatment for OS, PFS, LRFS, or DMFS (all p > 0.05) in the univariate and multivariate analyses. Patients treated with CCRT+AC had a higher incidence of grade 3 to 4 leucopenia (p=0.001) and neutropenia (p=0.001) than those treated with IC+CCRT. Conclusions: IC plus CCRT achieved comparable survival outcomes to CCRT plus AC and had a lower incidence of toxicity.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小蘑菇应助豆豆采纳,获得10
1秒前
仵一发布了新的文献求助10
2秒前
科研通AI2S应助虎福采纳,获得10
2秒前
orixero应助科研通管家采纳,获得10
3秒前
充电宝应助科研通管家采纳,获得10
3秒前
3秒前
科研通AI2S应助科研通管家采纳,获得10
3秒前
lonemen应助yaliswun采纳,获得10
3秒前
斯文败类应助科研通管家采纳,获得10
3秒前
Singularity应助科研通管家采纳,获得10
3秒前
英姑应助科研通管家采纳,获得30
4秒前
英姑应助科研通管家采纳,获得10
4秒前
4秒前
Singularity应助科研通管家采纳,获得10
4秒前
腿毛没啦应助科研通管家采纳,获得10
4秒前
科目三应助科研通管家采纳,获得10
4秒前
任性的仰应助科研通管家采纳,获得10
4秒前
大个应助科研通管家采纳,获得10
4秒前
科研通AI2S应助科研通管家采纳,获得10
4秒前
4秒前
大个应助科研通管家采纳,获得10
4秒前
在水一方应助科研通管家采纳,获得10
5秒前
Singularity应助科研通管家采纳,获得10
5秒前
桐桐应助科研通管家采纳,获得10
5秒前
5秒前
小鱼发布了新的文献求助10
6秒前
6秒前
ananchen完成签到,获得积分10
7秒前
8秒前
juanjuan应助清水采纳,获得10
9秒前
JamesPei应助小武wwwww采纳,获得10
9秒前
ssss发布了新的文献求助10
12秒前
老实的棉花糖完成签到,获得积分10
12秒前
威武怀蕊发布了新的文献求助10
13秒前
研友_VZG7GZ应助huaaaaaa1采纳,获得10
15秒前
16秒前
Jasper应助小鱼采纳,获得10
19秒前
呐殇发布了新的文献求助10
19秒前
友好的半仙完成签到,获得积分10
20秒前
21秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
Very-high-order BVD Schemes Using β-variable THINC Method 568
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3136624
求助须知:如何正确求助?哪些是违规求助? 2787645
关于积分的说明 7782625
捐赠科研通 2443718
什么是DOI,文献DOI怎么找? 1299386
科研通“疑难数据库(出版商)”最低求助积分说明 625429
版权声明 600954